← Eichor
Condition: Malignant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoi
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03422302The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539Evaluation of the Impact of Electronic Monitoring on Patient Compliance in Hematology
NA · 3 location(s) · Private Hospital of Confluent, France · NCT06713811Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-relat
Phase N/A · 1 location(s) · Air Force Military Medical University, China · NCT06118437Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hemato
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07235501GD2/CD56 Bi-specific CAR-T Cell Therapy
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT05437328Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
Phase 1 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07482592Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Hangzhou Hanx Biopharmaceuticals, Ltd. · NCT06708663The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · 19 location(s) · Merck Sharp & Dohme LLC · NCT07247110Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Angela Y. Jia, MD PhD · NCT06574880Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
NA · 2 location(s) · Emory University · NCT07213154A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
Phase 1/Phase 2 · 1 location(s) · SUNHO（China）BioPharmaceutical CO., Ltd. · NCT05991583MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07400224A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Phase 2 · 58 location(s) · Merck Sharp & Dohme LLC · NCT06979596Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
NA · 1 location(s) · Ain Shams University · NCT07147270Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NA · 21 location(s) · Hospices Civils de Lyon · NCT02838602Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Phase N/A · 5 location(s) · AZ Sint-Jan AV · NCT04007783A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Phase N/A · 1 location(s) · Xinhua Zhang, MD · NCT05464875Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
Phase N/A · 1 location(s) · Loyola University · NCT05728957Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Tr
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06314672ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT06959719A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
Phase 1 · 2 location(s) · Lee's Pharmaceutical Limited · NCT06953453
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.